Prohibiting Tianeptine and Other Dangerous Products Act of 2026
Analysis under review: This bill has generated analysis that may be too generic or incomplete. Clause-level evidence remains available below.
Summary
What This Bill Does
This bill, Prohibiting Tianeptine and Other Dangerous Products Act of 2026, changes federal law or congressional policy affecting health care providers and patients. The main policy domain is Healthcare, Environment, Agriculture.
Who Benefits and How
health care providers and patients may benefit from new authority, funding, eligibility, regulatory clarity, or reduced risk created by the bill.
Who Bears the Burden and How
federal implementing agencies, health care providers and patients may take on implementation duties, reporting obligations, compliance costs, or oversight responsibilities.
Key Provisions
- Section H4F8A9A4D1E754FEEA9BA2A5F99C15FFD: 1. Short title This Act may be cited as the Prohibiting Tianeptine and Other Dangerous Products Act of 2026.
- Section H62469DAD2EEC4570ACA581B7C0577488: 2. New prohibited acts relating to dietary supplements Section 301 of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 331) is amended by adding at the end...
Evidence Chain:
This summary is generated from the full bill text using AI analysis. Expand "Detailed Analysis" below for identified beneficiaries/burden bearers.
At a Glance
What This Bill Does
This bill, Prohibiting Tianeptine and Other Dangerous Products Act of 2026, changes federal law or congressional policy affecting health care providers and patients.
Key Policy Areas
Healthcare, Environment, Agriculture
Primary Purpose
This bill, Prohibiting Tianeptine and Other Dangerous Products Act of 2026, changes federal law or congressional policy affecting health care providers and patients.
Policy Domains
Whole bill
Identified Gains
Contextual inference, no direct clause citation- health care providers and patients
Contextual inference, no direct clause citation
Identified Costs
Contextual inference, no direct clause citation- federal implementing agencies
- health care providers and patients
Contextual inference, no direct clause citation
Legislative Progress
In CommitteeReferred to the House Committee on Energy and Commerce.
Introduced in House
Mr. Pallone introduced the following bill; which was referred to …
Bill Structure & Actor Mappings
Who is "The Secretary" in each section?
- "federal_implementing_agencies"
- → Federal agencies assigned duties by the bill
We use a combination of our own taxonomy and classification in addition to large language models to assess meaning and potential beneficiaries. High confidence means strong textual evidence. Always verify with the original bill text.
Learn more about our methodology